Real-world Data on the Efficacy and Safety of Ixazomib-based Therapy in Multiple Myeloma: A Single-center Study in China

Real-world Data on the Efficacy and Safety of Ixazomib-based Therapy in Multiple Myeloma: A Single-center Study in China

Kai Ding ,* Hong Yu ,* Yuan-Yuan Shao, Li-Yan Li, Chao-Meng Wang, Jia Song, Li-Juan Li, Rong Fu Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, People’s Republic of China*These authors contributed equally to this workCorrespondence: Rong Fu Tel +86-18...

Full description

Bibliographic Details
Main Authors: Ding K, Yu H, Shao YY, Li LY, Wang CM, Song J, Li LJ, Fu R
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Cancer Management and Research
Subjects:
multiple myeloma
ixazomib
real world
overall response rate
adverse events
Online Access:https://www.dovepress.com/real-world-data-on-the-efficacy-and-safety-of-ixazomib-based-therapy-i-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/real-world-data-on-the-efficacy-and-safety-of-ixazomib-based-therapy-i-peer-reviewed-article-CMAR

Similar Items